Balzan Prize for Michael N. Hall of the University of Basel

Home > News > Diabetes-Nachrichten > Archive > 2024 > 240909

The result of Hall’s heritage of Protein TOR plays in another role in diabetes management

Prof. Dr. Michael N. Hall from the Biozentrum of the University of Basel has received the Balzan Prize 2024 for his research into the biological mechanisms of the alternatives. The cell biologist can discover a key element for the control of the cell membranes with the research of the proteins TOR (Target of Rapamycin), which is played a role in the development, the alteration and a high probability of diseases with Krebs and Diabetes.

Michael N. Hall has requested the Balzan Prize for his railway breakings in the development of the molecular mechanisms, which are the Zellwachstum and the Alternative regulars. Michael Hall used proteins, TOR1 and TOR2, which contain the cooking liquid and the substance in the composition of regular Nährstoffen. These games play a central role in the change phase and in the change of the disease values ​​such as Krebs, Diabetes and Herz-Kreislauf-Erkrankungen.

We read winners and recipients of the 2024 Balzan Prizes from Australian National University criminologist John Braithwaite, science historian Lorraine Daston, director of the Max Planck Institute for the History of Science and American chemist Omar Yaghi from the University of California Berkeley.

The four preisträgerinnen and preisträger are said to have found the international Balzan Foundation in Milan. The Balzan prizes were developed for the legal science of the history of science and the biology of the alternatives to innovative materials. The prize is worth 750,000 francs, but work is being done on the fact that the preisträgerinnen and the preisträger use half of the prize money for the financing of used research projects, a new generation of nachwuchsforschenden that is used. The Prize Lecture will take place on November 21 in Rome in the event of the President of the Italian Republic.

Vielfach ausgezeichneter Forscher

See more than three years ago Prof. Michael N. Hall at the Biozentrum of the Universität Basel. Here you will find the 1990s with Protein Target or Rapamycin, kurz TOR. During the An- and Abschalten different Signalwege control on the Wachstum and the Grosse von Zellen. A further improvement of the overall TOR signal network is connected with alternative reproduction of the Entstehung von Krebs and Diabetes.

In the course of the year the Hall blessing could puzzle the next lid further. So if there is still TOR in the protein complex and it can be that TOR in the Zelle works in an unhealthy way. With the use of the Verstandnis of Zellwachstum and Alternative legendary changing and which Anhaltspunkte for the Entwicklung new artiger Krebsmedikamenten geliefert.

Michael N. Hall, 71, was born in Puerto Rico and spent his childhood and youth in Venezuela and Peru. After receiving his doctorate from Harvard University, he is a postdoctoral fellow at the Pasteur Institute in Paris and at the University of California, San Francisco. In 1987, Hall became an assistant professor and Biocenter of the University of Basel. Since 1992, he has been teaching and researching here as a professor of biochemistry. He is a research group leader at the Institute for Human Biology in Basel, which was founded by Roche in 2023.

For their own pioneering work, they achieved high-quality research, including the Louis Jeantet Prize for Medicine (2009), the Marcel Benoist Prize for Science in Human Medicine (2012), the Breakthrough Prize in Life Sciences (2014), in Canada Gairdner International Prize (2015), the Lasker Award (2017) and the Sjöberg Prize (2020). In 2014, Mike Hall was inducted into the American National Academy of Sciences. In January 2021 the Ehrendoktorwürde der Hebräischen Universität Jerusalem would be lost.

Michael N. Hall is the second researcher of the University of Basel, a Balzan Prize honors: The Entwicklungsbiologist Prof. Walter Gehring, ebenfalls vom Biozentrum, war 2002 damit ausgezeichnet zijn.

will be updated: 09.09.2024